190 related articles for article (PubMed ID: 32435059)
1. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
Su S; Jiang S
Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059
[No Abstract] [Full Text] [Related]
2. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
[No Abstract] [Full Text] [Related]
3. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
4. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.
Milne S; Yang CX; Timens W; Bossé Y; Sin DD
Lancet Respir Med; 2020 Jun; 8(6):e50-e51. PubMed ID: 32411576
[No Abstract] [Full Text] [Related]
6. Skin is a potential host of SARS-CoV-2: A clinical, single-cell transcriptome-profiling and histologic study.
Sun Y; Zhou R; Zhang H; Rong L; Zhou W; Liang Y; Li Q
J Am Acad Dermatol; 2020 Dec; 83(6):1755-1757. PubMed ID: 32822795
[No Abstract] [Full Text] [Related]
7. Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing.
Zecha J; Lee CY; Bayer FP; Meng C; Grass V; Zerweck J; Schnatbaum K; Michler T; Pichlmair A; Ludwig C; Kuster B
Mol Cell Proteomics; 2020 Sep; 19(9):1503-1522. PubMed ID: 32591346
[TBL] [Abstract][Full Text] [Related]
8. Could angiotensin-converting enzyme 1
Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
[No Abstract] [Full Text] [Related]
9. Genetic predisposition models to COVID-19 infection.
Darbeheshti F; Rezaei N
Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414
[No Abstract] [Full Text] [Related]
10. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
Alshahawey M; Raslan M; Sabri N
Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
[No Abstract] [Full Text] [Related]
11. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.
Du M; Cai G; Chen F; Christiani DC; Zhang Z; Wang M
Gastroenterology; 2020 Jun; 158(8):2298-2301.e7. PubMed ID: 32234303
[No Abstract] [Full Text] [Related]
12. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.
Singh KK; Chaubey G; Chen JY; Suravajhala P
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C258-C267. PubMed ID: 32510973
[TBL] [Abstract][Full Text] [Related]
13. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.
Novelli A; Biancolella M; Borgiani P; Cocciadiferro D; Colona VL; D'Apice MR; Rogliani P; Zaffina S; Leonardis F; Campana A; Raponi M; Andreoni M; Grelli S; Novelli G
Hum Genomics; 2020 Sep; 14(1):29. PubMed ID: 32917283
[TBL] [Abstract][Full Text] [Related]
14. Sodium status and kidney involvement during COVID-19 infection.
Post A; Dullaart RPF; Bakker SJL
Virus Res; 2020 Sep; 286():198034. PubMed ID: 32445872
[TBL] [Abstract][Full Text] [Related]
15. [Genetic and epigenetic variability, and the Covid-19 pandemic].
Rivera-Silva G
Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
[No Abstract] [Full Text] [Related]
16. ACE2 Expression and Risk Factors for COVID-19 Severity in Patients with Advanced Age.
Tavares CAM; Avelino-Silva TJ; Benard G; Cardozo FAM; Fernandes JR; Girardi ACC; Jacob Filho W
Arq Bras Cardiol; 2020 Oct; 115(4):701-707. PubMed ID: 33111872
[No Abstract] [Full Text] [Related]
17. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.
Lee S; Yoon GY; Myoung J; Kim SJ; Ahn DG
Emerg Microbes Infect; 2020 Dec; 9(1):2169-2179. PubMed ID: 32969768
[TBL] [Abstract][Full Text] [Related]
18. [Are there genetic variants that can modify the course of the COVID-19 pandemic?].
Azurmendi PJ
Medicina (B Aires); 2020; 80 Suppl 3():79-81. PubMed ID: 32658852
[No Abstract] [Full Text] [Related]
19. [ACE2 and coronavirus - a question of balance and dynamics?].
Lundström A; Sandén P
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
[TBL] [Abstract][Full Text] [Related]
20. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.
Tan CW; Chia WN; Qin X; Liu P; Chen MI; Tiu C; Hu Z; Chen VC; Young BE; Sia WR; Tan YJ; Foo R; Yi Y; Lye DC; Anderson DE; Wang LF
Nat Biotechnol; 2020 Sep; 38(9):1073-1078. PubMed ID: 32704169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
